India’s pharmaceutical industry is witnessing a surge in global partnerships, with countries such as Switzerland, Uzbekistan, ...
M&A was again a big feature in last week's news, with AbbVie’s acquisition of Apogee Therapeutics, along with its atopic ...
US biotech Viridian Therapeutics saw its shares climb more than 10% to $19.81 in after-hours activity Friday, when it ...
The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Keytruda (pembrolizumab), within ...
The European Commission (EC) has approved Maviret (glecaprevir/pibrentasvir) for the treatment of acute hepatitis C virus ...
CNX Therapeutics and Legacy Pharma have entered into a US commercial partnership for the launch of Ethyol (amifostine), with ...
US biopharma Definium Therapeutics has closed an upsized public offering that raised $805 million in gross proceeds, days ...
German drugmaker Merck KGaA said today it will acquire US biotech firm Bio-Techne Corp for $11.3 billion, expanding its ...
US genomic medicine company Sangamo Therapeutics has filed for Chapter 11 bankruptcy protection as it prepares to auction off ...
Northern Ireland-based Galen has secured an expanded UK license for Penthrox (methoxyflurane), allowing the emergency pain ...
Paris and Boston, USA-based clinical-stage biotech Bionyra Pharma, which is developing next-generation biologics for ...
US clinical-stage biotech Ollin Biosciences has raised $330 million in an oversubscribed Series B round to fund global Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results